| Product NDC: | 55390-560 |
| Proprietary Name: | Dobutamine |
| Non Proprietary Name: | Dobutamine hydrochloride |
| Active Ingredient(s): | 12.5 mg/mL & nbsp; Dobutamine hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-560 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074277 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950102 |
| Package NDC: | 55390-560-90 |
| Package Description: | 10 VIAL in 1 BOX (55390-560-90) > 20 mL in 1 VIAL |
| NDC Code | 55390-560-90 |
| Proprietary Name | Dobutamine |
| Package Description | 10 VIAL in 1 BOX (55390-560-90) > 20 mL in 1 VIAL |
| Product NDC | 55390-560 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dobutamine hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19950102 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Strength Number | 12.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |